• Keine Ergebnisse gefunden

Exercise to the lecture „Modern Methods in Drug Discovery“ WS21/22

N/A
N/A
Protected

Academic year: 2022

Aktie "Exercise to the lecture „Modern Methods in Drug Discovery“ WS21/22"

Copied!
2
0
0

Wird geladen.... (Jetzt Volltext ansehen)

Volltext

(1)

1

Exercise to the lecture „Modern Methods in Drug Discovery“ WS21/22 5th Assignment

your name:

1. The analgesic and anti-inflammatory Ibuprofen faced a series of „me-too“ drugs shortly after its commerical launch, since the corresponding patent claimed the structure of ibuprofen (see compound A), only.

COOH CH3

COOH CH3

O COOH

CH3

F

CH3 O COOH

C H3

COOH COOH

CH3 C N

H3

H

COOH CH3

O

COOH CH3 O

N Cl

COOH CH3 O

C O H3 Ibuprofen 1966 Upjohn

Fenoprofen 1971 Lilly Flurbiprofen 1973 Upjohn

Naproxen 1975 Syntec

Ibufenac 1968 Boots Pure Drug Alminoprofen 1971 Bouchera

Ketoprofen 1972 AHP

Benoxaprofen 1973 Lilly Bermoprofen 1970 Dainippon

A B C

D E F

G H I

Report the matching compounds(s) (alphabetic character is sufficient) for the given SMARTS 1 to 4. Not all compounds may me matched (5 points for each correct assignment, deduction if more than one is falsely assigned)

1: OC(=O)C(C)c1ccc([C,N])cc1

2: OC(=O)C(C)c1cccc([C,O,F])c1

3: OC(=O)C(C)c1cccc([#6])c1

4: OC(=O)C(C)c1cccc([C,O,#7])c1

Which compound is not matched by any of the SMARTS strings? (4 points)

(2)

2

2. Mark the correct value of the linear correlation for each of the plots, respectively

(9 points)

r2 = 0.00 r = –0.98 r2 = 0.00

r2 = 0.60 r = 0.00 r2 = 0.50

r2 = 0.90 r = 0.90 r2 = 0.60

r2 = 0.95 r = 0.98 r2 = 0.85

3. Which of the QSAR equations (A or B, respectively C or D) is „better“ ? (According to which criteria ?) (10 points)

n: number of molecules; r2: squared correlation coefficient;

q2: cross-validated r2; s: standard error

A) log 1/Ki = 0.26(0.14)ClogP – 1.36(0.43)NHB + 9.66(0.39)HL where n = 21, r2 = 0.853, q2 = 0.746, s = 0.326

B) log 1/Ki = 0.34(0.13)ClogP – 0.96(0.27)MR + 0.85(0.19)B5Y where n = 21, r2 = 0.853, q2 = 0.807, s = 0.302

C) log 1/C = 0.26(0.18)ClogP – 1.36(0.43)MR + 9.66(0.39)B5Y where n = 16, r2 = 0.821, q2 = 0.794, s = 0.354

D) log 1/C = 0.23(0.15)ClogP – 1.20(0.56)MR + 10.74(0.67)B5Y – 0.62(0.12)NN4 + 0.14( 0.05)GEOM6

where n = 16, r2 = 0.892, q2 = 0.632, s = 0.325

4. Chemical alterations shall be carried for the shown compounds. Draw a new structure that includes the suitable modifications. (12 points)

a) suggest a modification that reduces the b) suggest a modification that will lead to number of freely rotatable bonds increased metabolic stability of the lower

benzene ring

observed predicted

observed predicted

observed predicted

O NH2

N OH

N CH3

N H

Referenzen

ÄHNLICHE DOKUMENTE

1st Lecture Modern Methods in Drug Discovery WS21/22 2.. Flow of information in a drug

Write down the actual effective substance.Try to find its chemical structure and some information about its molecular

Compare the X-ray structures of tACE with the bound inhibitors lisinopril (1O86.pdb) and captopril (1UZF.pdb). a) Which amino acids form interactions with the zinc ion?. (list

In lectures 3 and 4 guidelines and criteria have been presented, which a chemical compound should possess for good oral bioavailability (molecular weight (MW), number of

Compare the X-ray structures of tACE with the bound inhibitors lisinopril (1O86.pdb) and captopril (1UZF.pdb). a) Which amino acids form interactions with the zinc ion?. (list

and search for captopril. In the corresponding compound entry scroll down to “Activity Charts”. Move mouse over the according slice in "Bioactivity Summary"

In lectures 3 and 4 guidelines and criteria have been presented, which a chemical compound should possess for good oral bioavailability (molecular weight (MW), number of

The analgesic and anti-inflammatory Ibuprofen faced a series of „me-too“ drugs shortly after its commerical launch, since the corresponding patent claimed the structure